Biomarker

Fasting insulin

Fasting insulin is a biomarker that measures the level of insulin in your blood after at least 8 hours without food, and it provides insights into how well your body manages glucose levels. Higher fasting insulin levels have been linked to an increased risk of coronary artery disease through various biological pathways, as identified in a proteome-wide Mendelian randomization study. Additionally, a dose-response meta-analysis found that elevated fasting insulin is associated with higher cancer-related mortality in non-diabetic adults. For individuals managing type 2 diabetes, consensus guidelines recommend careful adjustment of insulin doses during periods of fasting to maintain stable blood glucose levels.

Fasting insulin also plays a role in preoperative protocols and has been studied for optimal fasting times before medical procedures. In the context of Ramadan fasting, studies have explored how insulin pump therapy can be effectively managed to prevent hypoglycemia and maintain glucose control in individuals with type 1 diabetes.

While these findings highlight important connections between fasting insulin and various health outcomes, more research is needed to fully understand the underlying mechanisms and their clinical implications.

Fasting insulin

Sources

Connections

Fasting insulin measures

Sources

Local graph